Oxford Immunotec Global PLC Ordinary Shares
OXFD
OXFD was delisted on the 5th of March, 2021.
49 hedge funds and large institutions have $171M invested in Oxford Immunotec Global PLC Ordinary Shares in 2014 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 6 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
50% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 12
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
0% more funds holding
Funds holding: 49 → 49 (0)
4% less capital invested
Capital invested by funds: $178M → $171M (-$7.07M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$1.14M |
| 2 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
+$925K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$695K |
| 4 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
+$553K |
| 5 |
PSC
Piper Sandler & Co
Minneapolis,
Minnesota
|
+$355K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
-$3.32M |
| 2 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
-$763K |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$360K |
| 4 |
WCM
Waterstone Capital Management
St. Louis Park,
Minnesota
|
-$326K |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$230K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
BNP Paribas Financial Markets
Paris,
France
| – | -$17.5K | -1,147 | Closed |
|
|
PAM
52
Panagora Asset Management
Boston,
Massachusetts
| – | -$16K | -1,065 | Closed |
|
53
Morgan Stanley
New York
| – | -$7.16K | -524 | -98% |
|
54
Bank of America
Charlotte,
North Carolina
| – | -$2K | -161 | Closed |
|
55
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$178 | +13 | New |
|
OXFD Hedge Fund Activity: Q4 2014 in Review
49 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q4 2014, worth a combined $171M — down 4% from $178M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new OXFD positions and 6 closed out — a net gain of 1 holder — while 18 added to existing stakes and 12 trimmed.
The largest buyer was First Light Asset Management, adding an estimated $1.14M. The largest seller was Next Century Growth Investors, exiting entirely with an estimated $3.32M sold.
- 49 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q4 2014, unchanged from Q3 2014.
- Funds reported $171M of Oxford Immunotec Global PLC Ordinary Shares stock for Q4 2014, down 4% quarter-over-quarter.
- 7 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q4 2014 and 6 closed out, a net change of +1 holder.
- The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q4 2014 was First Light Asset Management, an estimated $1.14M added.
- The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q4 2014 was Next Century Growth Investors, an estimated $3.32M sold.
Based on aggregated 13F filings for Q4 2014.